[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-356297-105":59,"doc-detail-356297-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","optimising-response-assessment-to-neoadjuvant-therapy-in-rectal-cancer-to-reduce-the-incidence-of-ypt0n0-resection","Optimising response assessment to neoadjuvant therapy in rectal cancer to reduce the incidence of ypT0N0 resection","","Local response assessment after neo-adjuvant therapy for rectal cancer integrates DRE, endoscopy and pelvic MRI, yet discordance can lead to patients being misclassified as having persistent tumour or recurrence, driving overtreatment. This retrospective cohort study examined individuals achieving complete pathological response (ypT0N0) after neo-adjuvant treatment, identified from Royal North Shore Hospital MDT cases (Jan 2016–Dec 2024). MDT decision-making was evaluated using discussion records and clinical outcomes.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/optimising-response-assessment-to-neoadjuvant-therapy-in-rectal-cancer-to-reduce-the-incidence-of-ypt0n0-resection/356297/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/optimising-response-assessment-to-neoadjuvant-therapy-in-rectal-cancer-to-reduce-the-incidence-of-ypt0n0-resection/356297.png","ImageObject",300,407,{"name":92,"@type":93},"Olivia Brown","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What clinical tools are used to assess local response to neo-adjuvant therapy in rectal cancer?","Question",{"text":112,"@type":113},"Assessment incorporates digital rectal exam (DRE), endoscopy and pelvic MRI.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How many patients achieved complete pathological response (ypT0N0) in the study cohort?",{"text":117,"@type":113},"Twelve patients (17%) had ypT0N0 pathology among those proceeding to surgery.",{"name":119,"@type":110,"acceptedAnswer":120},"Why does the study conclude overtreatment remains a concern, and what is the proposed management approach?",{"text":121,"@type":113},"Discordant investigations contribute to misidentification of tumour persistence or recurrence, prompting unnecessary resections. Management decisions based on concordance of investigations may reduce the number of ypT0N0 resections.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},356297,1790186132,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},16904993612988,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","International Journal of Colorectal Disease (2026) 41:50  \n[https://doi.org/10.1007/s00384-025-05034-1](https://doi.org/10.1007/s00384-025-05034-1)  \nOptimising response assessment to neoadjuvant therapy in rectal cancer to reduce the incidence of ypT0N0 resection  \nJonathan Hew1,2 · Ali Mohtashami1,2 · Katerina Mastrocostas5 · Tracey Skinner1 · Keshani De Silva6 · Nick Pavlakis2,4 · George Hruby2,3 · Justin Evans1 · Yasser Salama1 · Andrew Kneebone2,3 · Kah Hoong Chang1,2  \nReceived: 5 July 2025 / Accepted: 5 November 2025 © The Author(s) 2026  \nAbstract  \nPurpose Assessment of local response to neo-adjuvant therapy for rectal cancer incorporates digital rectal exam (DRE), endoscopy and pelvic MRI. Despite this process patients are mistakenly identified with tumour persistence or recurrence resulting in overtreatment. This retrospective cohort study aimed to investigate the assessment of patients who had a complete pathological response (ypT0N0) after neo-adjuvant treatment for rectal cancer and evaluate clinical decision making. Method ypT0N0 cases were identified from a cohort of patients discussed at the Royal North Shore Hospital Colorectal Cancer Multidisciplinary Meeting (MDT) treated for rectal cancer from January 2016 to December 2024. The medical record was accessed to retrieve clinical information. Decision making was assessed from MDT discussion records.  \nResults 110 patients were treated with neo-adjuvant therapy during the study period, with 71 proceeding to surgery. Twelve patients (17%) had ypT0N0 pathology. The decision to resect was prompted by concerning tumour signal on MRI (10/11), endoscopic evidence of tumour (3/6), palpable disease on DRE (3/9) and biopsy (2/3) . Discordant investigations were common. The sensitivity and specificity of MDT decisions for complete clinical response were 61% and 95% respectively. Patients underwent either abdominal perineal resection or ultralow anterior resection; (6/12) experienced Clavien-Dindo 3 or 4 complications.  \nConclusions The clinical assessment of response to neo-adjuvant therapy in patients with rectal cancer is an area that requires improvement due to overtreatment. ypT0N0 patients often have discordant investigations. Management decisions based on the concordance of investigations may reduce the number of ypT0N0 resections.  \nKeywords Rectal cancer · Neo-adjuvant therapy · Total mesorectal excision · Watch and wait  \n* Kah Hoong Chang [Kahhoong.chang@sydney.edu.au](Kahhoong.chang@sydney.edu.au)  \n1 Department of Colorectal Surgery, Royal North Shore Hospital, Reserve Road St Leonards, Sydney, NSW, Australia  \n2 Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia  \n3 Department of Radiation Oncology, Royal North Shore Hospital, Sydney, NSW, Australia  \n4 Department of Medical Oncology, Royal North Shore Hospital, Sydney, NSW, Australia  \n5 Department of Radiology, Royal North Shore Hospital, Sydney, NSW, Australia  \n6 Department of Anatomical Pathology, Royal North Shore Hospital, Sydney, NSW, Australia  \nBackground  \nOrgan preservation after total neo-adjuvant therapy (TNT) with attainment of a complete clinical response (cCR) is a common pathway for the management of locally advanced rectal cancer [1, 2] . A three-tiered approach incorporates digital rectal exam (DRE), endoscopy and pelvic MRI to select patients suitable for watch and wait (WW) facilitating organ preservation [2–5] . In the OPRA study patients were categorised into either those with a complete clinical response (40%) or near complete response (32%) and enter WW or an incomplete response (28%) and recommended resection [6, 7] . The exact protocol of assessment and surveillance is institute-dependent with the method, frequency, modality and intervals between investigations varying.  \nFailure to achieve a cCR or detection of recurrence on a WW program is an indication for Total Mesorectal Excision  \n(TME). In the OPRA study 8–9% of patients who completed TNT and under","cbCaivSRqlu4yJox","https://ap.wps.com/l/cbCaivSRqlu4yJox","pdf",1117181,11,"English","# Abstract\n## Purpose\n## Method\n## Results\n## Conclusions\n# Background\n# Method\n## Study population\n## Neo-adjuvant management","[{\"question\":\"What clinical tools are used to assess local response to neo-adjuvant therapy in rectal cancer?\",\"answer\":\"Assessment incorporates digital rectal exam (DRE), endoscopy and pelvic MRI.\"},{\"question\":\"How many patients achieved complete pathological response (ypT0N0) in the study cohort?\",\"answer\":\"Twelve patients (17%) had ypT0N0 pathology among those proceeding to surgery.\"},{\"question\":\"Why does the study conclude overtreatment remains a concern, and what is the proposed management approach?\",\"answer\":\"Discordant investigations contribute to misidentification of tumour persistence or recurrence, prompting unnecessary resections. Management decisions based on concordance of investigations may reduce the number of ypT0N0 resections.\"}]","Optimising response assessment to neoadjuvant therapy in rectal cancer to reduce the incidence of ypT0N0 resection | PDF",1790124482,28,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/730a4718dd3e385fa9b7a1ca6c2b4111.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a8ad171bd8ba10934544b227adb2d1bd.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7866f3c0fe60a4fd24b5d576761fa923.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a398f41f3fdc75ab78e796a018e35c7a.webp",980,1301]